Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure

Details for Australian Patent Application No. 2006272612 (hide)

Owner Regenerx Biopharmaceuticals, Inc.

Inventors Crockford, David

Agent Wrays

Pub. Number AU-B-2006272612

PCT Pub. Number WO2007/014253

Priority 60/702,269 26.07.05 US

Filing date 26 July 2006

Wipo publication date 1 February 2007

Acceptance publication date 6 October 2011

International Classifications

C07K 5/00 (2006.01) Peptides having up to four amino acids in a fully defined sequence

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/04 (2006.01) Medicinal preparations containing peptides - Peptides having up to 20 amino acids in a fully defined sequence

C07K 7/00 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 17/00 (2006.01) Carrier-bound or immobilised peptides

Event Publications

20 March 2008 PCT application entered the National Phase

  PCT publication WO2007/014253 Priority application(s): WO2007/014253

6 October 2011 Application Accepted

  Published as AU-B-2006272612

2 February 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006272616-Multicellular metabolic models and methods

2006272609-Abl kinase inhibition